92 related articles for article (PubMed ID: 7871391)
1. Induction of anti-tumour immunity in syngeneic mice by a leukaemic cell line.
Mongini C; Waldner CI; Alvarez E; Roig MI; Sánchez Lockhart M; Gravisaco MJ; Hajos SE
Scand J Immunol; 1995 Mar; 41(3):298-304. PubMed ID: 7871391
[TBL] [Abstract][Full Text] [Related]
2. [Immunobiological characterization of murine LB leukemia and the LBC cell line].
Hajos SE; Mongini C; Waldner C; Sánchez Lockhart M; Gravisaco MJ; Roig I; Fernańdez T; Alvarez E
Medicina (B Aires); 1996; 56 Suppl 1():45-56. PubMed ID: 9224974
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of anti-tumour immunity in syngeneic mice after MHC class II gene transfection.
Mongini C; Sánchez Lockhart M; Waldner CI; Alvarez EM; Gravisaco MJ; Roig MI; Hajos SE
Br J Cancer; 1996 Jul; 74(2):258-63. PubMed ID: 8688332
[TBL] [Abstract][Full Text] [Related]
4. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
[TBL] [Abstract][Full Text] [Related]
5. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
6. Adoptive transfer enables tumor rejection targeted against a self-antigen without the induction of autoimmunity.
Eck SC; Turka LA
Cancer Res; 2001 Apr; 61(7):3077-83. PubMed ID: 11306490
[TBL] [Abstract][Full Text] [Related]
7. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice.
Wang YC; Zhu L; McHugh R; Sell KW; Selvaraj P
Eur J Immunol; 1995 May; 25(5):1163-7. PubMed ID: 7774619
[TBL] [Abstract][Full Text] [Related]
8. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
[TBL] [Abstract][Full Text] [Related]
9. Induction of T-cell immunity against Ras oncoproteins by soluble protein or Ras-expressing Escherichia coli.
Fenton RG; Keller CJ; Hanna N; Taub DD
J Natl Cancer Inst; 1995 Dec; 87(24):1853-61. PubMed ID: 7494229
[TBL] [Abstract][Full Text] [Related]
10. Selective purging by human interleukin-2 activated lymphocytes of bone marrows contaminated with a lymphoma line or autologous leukaemic cells.
Gambacorti-Passerini C; Rivoltini L; Fizzotti M; Rodolfo M; Sensi ML; Castelli C; Orazi A; Polli N; Bregni M; Siena S
Br J Haematol; 1991 Jun; 78(2):197-205. PubMed ID: 2064957
[TBL] [Abstract][Full Text] [Related]
11. Anti-T-cell humoral and cellular responses in healthy BALB/c mice following immunization with ovalbumin or ovalbumin-specific T cells.
Zhang XY; Liu XG; Wang W; Wang WC; Gao XM
Immunology; 2003 Apr; 108(4):465-73. PubMed ID: 12667208
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
Lynch DH; Gurish MF; Daynes RA
Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
[TBL] [Abstract][Full Text] [Related]
13. B30-MDP, a synthetic muramyl dipeptide derivative for tumour vaccination to enhance antitumour immunity and antimetastatic effect in mice.
Yoo YC; Saiki I; Sato K; Azuma I
Vaccine; 1992; 10(11):792-7. PubMed ID: 1441733
[TBL] [Abstract][Full Text] [Related]
14. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
Haubeck HD; Kölsch E
Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
[TBL] [Abstract][Full Text] [Related]
15. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
[TBL] [Abstract][Full Text] [Related]
16. Resistance to syngeneic lymphoma cells as a result of immunization with chemically modified allogeneic lymphoma cells in mice.
Gillette RW; Berringer DC; Wunderlich DA
J Natl Cancer Inst; 1978 Jun; 60(6):1427-32. PubMed ID: 650705
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory activity of soluble IL-2R in sera, ascites and culture supernatants from murine leukaemic cells.
Waldner C; Mongini C; Alvarez E; Roig I; Hajos SE
Scand J Immunol; 1994 Sep; 40(3):308-16. PubMed ID: 8091130
[TBL] [Abstract][Full Text] [Related]
18. Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacy.
Rosato A; Zoso A; Milan G; Macino B; Dalla Santa S; Tosello V; Di Carlo E; Musiani P; Whalen RG; Zanovello P
J Immunol; 2003 Nov; 171(10):5172-9. PubMed ID: 14607917
[TBL] [Abstract][Full Text] [Related]
19. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
[TBL] [Abstract][Full Text] [Related]
20. Significance of cytotoxic lymphocytes after various immunizing procedures in a virus-induced non-producer syngeneic system: correlation between in vitro and in vivo lytic activity.
Pioch Y; Gerber M; Serrou B
Br J Cancer; 1980 Aug; 42(2):275-83. PubMed ID: 6448617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
